Revenue
2023
2024
2025
Ping An Biomedical Co., Ltd. (PASW)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | ¥34.1M | ¥87.6M | ¥82.6M |
| Gross profit | ¥949,505 | ¥5.4M | ¥4.2M |
| Operating expenses | ¥15.7M | ¥5.4M | ¥3.6M |
| Operating income | −¥14.7M | −¥2,039 | ¥612,481 |
| Net income | −¥12.8M | −¥1.3M | −¥993,937 |
| Basic EPSper diluted share | -CN¥0.69 | -CN¥0.07 | -CN¥0.06 |
| Diluted EPSper diluted share | -CN¥0.69 | -CN¥0.07 | -CN¥0.06 |